| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 28 Feb 25 | LEVI Levi Strauss & Co. | Class A Common Stock | Grant | Acquire A | No | No | 0 | 56 | 0.00 | 52,077 |
| 28 Feb 25 | LEVI Levi Strauss & Co. | Class B Common Stock Class A Common Stock | Grant | Acquire A | No | No | 0 | 99 | 0.00 | 122,573 |
| 6 Feb 25 | RVNC Revance Therapeutics | Common Stock | Sale back to company | Dispose D | No | No | 0 | 15,000 | 0.00 | 0 |
| 4 Feb 25 | RVNC Revance Therapeutics | Common Stock | Dispose U | No | No | 3.65 | 28,606 | 104.41 k | 15,000 | |
| 14 Nov 24 | LEVI Levi Strauss & Co. | Class A Common Stock | Grant | Acquire A | No | No | 0 | 60 | 0.00 | 52,021 |
| 14 Nov 24 | LEVI Levi Strauss & Co. | Class B Common Stock Class A Common Stock | Grant | Acquire A | No | No | 0 | 106 | 0.00 | 122,474 |
| 20 Aug 24 | LEVI Levi Strauss & Co. | Class A Common Stock | Grant | Acquire A | No | No | 0 | 52 | 0.00 | 51,961 |
| 20 Aug 24 | LEVI Levi Strauss & Co. | Class B Common Stock Class A Common Stock | Grant | Acquire A | No | No | 0 | 93 | 0.00 | 122,368 |
| 23 May 24 | LEVI Levi Strauss & Co. | Class A Common Stock | Grant | Acquire A | No | No | 0 | 42 | 0.00 | 51,909 |
| 23 May 24 | LEVI Levi Strauss & Co. | Class B Common Stock Class A Common Stock | Grant | Acquire A | No | No | 0 | 74 | 0.00 | 122,275 |
